
zzso 2009 influenza zzso zzso is resistant to zzso leaving zzso zzso as the only therapeutic zzso Other zzso are considered to be associated with zzso and clinical zzso However, out of the surveillance programs, few studies analyze the presence of zzso zzso zzso in certain clinical zzso 

To define the frequency and role of resistance and zzso zzso in a specific clinical zzso patients with persistent infection by zzso 

zzso study of patients with persistent zzso infection admitted to our zzso 

zzso zzso were detected in zzso of cases with persistent infection zzso and in none of the zzso controls zzso These cases were initially infected with susceptible zzso that acquired resistance at different zzso after therapy with zzso zzso The first case zzso 2) was an zzso patient who rapidly acquired resistance 9 days after diagnosis (6 days on zzso and whose infection resolved after standard zzso zzso The second case zzso 3) was a patient with chronic zzso leukemia zzso and the longest viral persistence zzso zzso The resistance zzso was detected in the zzso taken on day 37 after diagnosis (30 days on zzso Once the resistance zzso was identified, zzso was zzso by zzso and the infection zzso In addition to zzso zzso resistance, zzso associated with zzso were also zzso The zzso zzso was not found in any case, whereas the zzso zzso was identified in three persistent cases but also in two zzso zzso In one patient, the zzso substitution coincided with the zzso resistant zzso 

zzso zzso were zzso at rather different zzso in zzso zzso cases with persistent infection by influenza zzso 

